Calendar

pharmadog

Week of Mar 2, 2026

Mar 2, 2026approval165d agoMETRONIDAZOLE — FDA approvalMETRONIDAZOLE

Sponsor: INNOGENIX. Form: TABLET. Route: ORAL

full page →METRONIDAZOLE →fda approvals ↗

Mar 2, 2026approval165d agoONDANSETRON HYDROCHLORIDE — FDA approvalondansetron hydrochloride CR

Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL

full page →ondansetron hydrochloride CR →fda approvals ↗

Mar 2, 2026approval165d agoVENOFER (IRON SUCROSE) — FDA approvalInternational Medication Systems Ltd

Sponsor: AM REGENT. Form: INJECTABLE. Route: INTRAVENOUS

full page →fda approvals ↗

Mar 2, 2026approval165d agoIMODIUM MULTI-SYMPTOM RELIEF (LOPERAMIDE HYDROCHLORIDE) — FDA approvalBionpharma Inc

Sponsor: KENVUE BRANDS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Mar 2, 2026approval165d agoOXCARBAZEPINE — FDA approvalOXCARBAZEPINE

Sponsor: EPIC PHARMA LLC. Form: TABLET. Route: ORAL

full page →OXCARBAZEPINE →fda approvals ↗

Mar 2, 2026approval165d agoRIVAROXABAN — FDA approvalRIVAROXABAN

Sponsor: APOTEX. Form: FOR SUSPENSION. Route: ORAL

full page →RIVAROXABAN →fda approvals ↗

Mar 2, 2026approval165d agoBOSULIF (BOSUTINIB MONOHYDRATE) — FDA approvalAlembic Pharmaceuticals Inc

Sponsor: PF PRISM CV. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Mar 2, 2026approval165d agoSODIUM ACETATE — FDA approvalSODIUM ACETATE

Sponsor: AMNEAL. Form: SOLUTION. Route: INTRAVENOUS

full page →SODIUM ACETATE →fda approvals ↗

Mar 2, 2026approval165d agoMOXIFLOXACIN HYDROCHLORIDE — FDA approvalMOXIFLOXACIN HYDROCHLORIDE

Sponsor: MACLEODS PHARMS LTD. Form: TABLET. Route: ORAL

full page →MOXIFLOXACIN HYDROCHLORIDE →fda approvals ↗

Mar 2, 2026approval165d agoBOSULIF (BOSUTINIB MONOHYDRATE) — FDA approvalAlembic Pharmaceuticals Inc

Sponsor: PF PRISM CV. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Mar 2, 2026grant165d agoTEXAS A&M AGRILIFE RESEARCH — NAMs-Decisions Center: New Approach Methods for Decisions on Industrial and C...

TR grant. $3,124,604. PI: Ivan Rusyn

full page →nih reporter ↗

Mar 2, 2026grant165d agoOREGON HEALTH & SCIENCE UNIVERSITY — Optimizing cAMP and PKA sensors for cell-specific dissection of neuronal circ...

MH grant. $2,039,804. PI: Isabelle Rhyssa Joe Eduria Baconguis

full page →nih reporter ↗

Mar 2, 2026grant165d agoUNIVERSITY OF PENNSYLVANIA — Harnessing XNAs to Expand the Genetic Toolkit for RNA Silencing and RNA editingUniversity of Pennsylvania

GM grant. $406,250. PI: LIJUN ZHOU

full page →nih reporter ↗

Mar 2, 2026grant165d agoNORTHEASTERN UNIVERSITY — Integrated mass spectrometry strategies to decipher metabolite-protein cross ...

GM grant. $434,000. PI: Owen Samuel Skinner

full page →nih reporter ↗

Mar 2, 2026grant165d agoUNIVERSITY OF COLORADO DENVER — Classification of Disease Associated B Cell Receptors in Multiple SclerosisUniversity of Colorado Denver

NS grant. $427,712. PI: WENDY B MACKLIN

full page →nih reporter ↗

Mar 2, 2026grant165d agoIOWA STATE UNIVERSITY — Transcriptome- and proteome-wide effects of circular RNAs of SMA genes

NS grant. $420,750. PI: RAVINDRA N SINGH

full page →nih reporter ↗

Mar 2, 2026grant165d agoUTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH — Development and Application of Nicotinic Acetylcholine Receptor Targeted Pept...University of Utah

GM grant. $500,500. PI: J MICHAEL MCINTOSH

full page →nih reporter ↗

Mar 2, 2026grant165d agoNEW YORK UNIVERSITY — Replay-Driven Task Orthogonalization and Abstraction for Continual LearningNew York University

MH grant. $75,052. PI: Zhenglong Zhou

full page →nih reporter ↗

Mar 3, 2026approval164d agoBOSENTAN — FDA approvalBOSENTAN

Sponsor: WATSON LABS INC. Form: TABLET. Route: ORAL

full page →BOSENTAN →fda approvals ↗

Mar 3, 2026approval164d agoBOSENTAN — FDA approvalZydus Therapeutics Inc

Sponsor: ZYDUS PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Mar 3, 2026approval164d agoBOSENTAN — FDA approvalJanssen-Cilag Holdings Inc (Inactive)

Sponsor: SUN PHARM. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Mar 3, 2026approval164d agoBOSENTAN — FDA approvalZydus Therapeutics Inc

Sponsor: ZYDUS PHARMS. Form: TABLET, FOR SUSPENSION. Route: ORAL

full page →fda approvals ↗

Mar 3, 2026approval164d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalACS Dobfar SpA

Sponsor: ISTITUTO BIO ITA SPA. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Mar 3, 2026approval164d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalACS Dobfar SpA

Sponsor: ISTITUTO BIO ITA SPA. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Mar 3, 2026approval164d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalACS Dobfar SpA

Sponsor: ISTITUTO BIO ITA SPA. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Mar 3, 2026approval164d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalACS Dobfar SpA

Sponsor: ISTITUTO BIO ITA SPA. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Mar 3, 2026approval164d agoBOSENTAN — FDA approvalBOSENTAN

Sponsor: NATCO PHARMA LTD. Form: TABLET, FOR SUSPENSION. Route: ORAL

full page →BOSENTAN →fda approvals ↗

Mar 3, 2026approval164d agoBOSENTAN — FDA approvalAmneal Pharmaceuticals, Inc.

Sponsor: AMNEAL PHARMS CO. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Mar 3, 2026approval164d agoBOSENTAN — FDA approvalJanssen-Cilag Holdings Inc (Inactive)

Sponsor: PH HEALTH. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Mar 3, 2026approval164d agoFLUTICASONE PROPIONATE — FDA approvalFougera Pharmaceuticals Inc

Sponsor: GLENMARK SPECLT. Form: AEROSOL, METERED. Route: INHALATION

full page →fda approvals ↗

Mar 3, 2026approval164d agoTRACLEER (BOSENTAN) — FDA approvalJanssen-Cilag Holdings Inc (Inactive)

Sponsor: ACTELION. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Mar 3, 2026approval164d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalACS Dobfar SpA

Sponsor: ISTITUTO BIO ITA SPA. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Mar 3, 2026approval164d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalACS Dobfar SpA

Sponsor: ISTITUTO BIO ITA SPA. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Mar 3, 2026approval164d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalACS Dobfar SpA

Sponsor: ISTITUTO BIO ITA SPA. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Mar 3, 2026approval164d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalACS Dobfar SpA

Sponsor: ISTITUTO BIO ITA SPA. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Mar 3, 2026approval164d agoBOSENTAN — FDA approvalBOSENTAN

Sponsor: NATCO PHARMA LTD. Form: TABLET. Route: ORAL

full page →BOSENTAN →fda approvals ↗

Mar 3, 2026approval164d agoLETROZOLE — FDA approvalYiling Pharmaceutical Ltd

Sponsor: PHARMOBEDIENT. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Mar 3, 2026approval164d agoLETROZOLE — FDA approvalYiling Pharmaceutical Ltd

Sponsor: PHARMOBEDIENT. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Mar 3, 2026approval164d agoTRACLEER (BOSENTAN) — FDA approvalJanssen-Cilag Holdings Inc (Inactive)

Sponsor: ACTELION. Form: TABLET, FOR SUSPENSION. Route: ORAL

full page →fda approvals ↗

Mar 3, 2026grant164d agoVANDERBILT UNIVERSITY — Transcranial Functional Ultrasound in Adult Humans

EB grant. $542,947. PI: Brett C Byram

full page →nih reporter ↗

Mar 3, 2026grant164d agoUNIVERSITY OF MISSISSIPPI — Ionic liquid-assisted drug delivery to brain reservoirs for treatment of neur...

DA grant. $101,214. PI: Jason Richard Paris

full page →nih reporter ↗

Mar 3, 2026grant164d agoGORDON RESEARCH CONFERENCES — 2026 Immunoengineering Gordon Research Conference and Gordon Research Seminar

AI grant. $19,000. PI: Nicole Franziska Steinmetz

full page →nih reporter ↗

Mar 3, 2026grant164d agoKEYSTONE SYMPOSIA — RNA Modifications: Bridging Biological Function and Therapeutic Potential

CA grant. $10,000. PI: TERRY L. SHEPPARD

full page →nih reporter ↗

Mar 3, 2026grant164d agoMAYO CLINIC ROCHESTER — Acute Kidney Injury in Care Transitions: The ACT Pragmatic TrialMayo Clinic

DK grant. $796,370. PI: Erin Frazee Barreto

full page →nih reporter ↗

Mar 3, 2026grant164d agoKEYSTONE SYMPOSIA — Cancer Immunotherapy: Basic Mechanisms Informing Clinical Applications & Comb...

CA grant. $5,000. PI: TERRY L. SHEPPARD

full page →nih reporter ↗

Mar 3, 2026grant164d agoMICHIGAN STATE UNIVERSITY — Probing nucleolus function in a mouse model of fragile X syndrome

MH grant. $416,859. PI: Hongbing Wang

full page →nih reporter ↗

Mar 3, 2026grant164d agoUNIVERSITY OF CALIFORNIA, SAN DIEGO — Functional RNA elements in the human genomeUniversity of California San Diego

HG grant. $785,329. PI: Kevin Daniel Corbett

full page →nih reporter ↗

Mar 4, 2026approval163d agoBAL (DIMERCAPROL) — FDA approvalAkorn Operating Company LLC (Inactive)

Sponsor: PROVEPHARM SAS. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Mar 4, 2026approval163d agoROCURONIUM BROMIDE — FDA approvalROCURONIUM BROMIDE

Sponsor: ASPIRO. Form: INJECTABLE. Route: INJECTION

full page →ROCURONIUM BROMIDE →fda approvals ↗

Mar 4, 2026approval163d agoEMTRICITABINE, RILPIVIRINE AND TENOFOVIR DISOPROXIL FUMARATE (EMTRICITABINE) — FDA approvalHetero USA Inc

Sponsor: LAURUS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

← prev

page 1 of 33

Week of Mar 2, 2026